The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
CD4+ T Cell Help Confers a Cytotoxic T Cell Effector Program Including Coinhibitory Receptor Downregulation and Increased Tissue Invasiveness
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Oncology meets immunology: the cancer-immunity cycle.
Chen, D. S., & Mellman, I. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.012 · Cited by 6,929 · cited 5×
“It can also be expected that efficacy of CTLs depends on their ability to penetrate into effector tissues (Chen and Mellman, 2013).”
BackgroundResultInfluentialPD-1 blockade induces responses by inhibiting adaptive immune resistance
Tumeh, P. C., Harview, C. L., Yearley, J. H., Shintaku, I. P., Taylor, E. J. M., Robert, L., Chmielowski, B., Spasic, M., Henry, G., Ciobanu, V., et al. (2014) · Nature · doi:10.1038/nature13954 · Cited by 6,609 · cited 1×
“In multiple cancer types, CD8+ T cells were found to be excluded from the vicinity of tumor cells, which correlates to a poor clinical outcome (Galon et al., 2006) and a negative response to anti-PD1 treatment (Tumeh et al., 2014).”
BackgroundType, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Transcriptional control of effector and memory CD8+ T cell differentiation
Kaech, S. M., & Cui, W. (2012) · Nature Reviews Immunology · doi:10.1038/nri3307 · Cited by 1,628
Melief, C. J. M., van Hall, T., Arens, R., Ossendorp, F., & van der Burg, S. H. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80009 · Cited by 1,164
Salmon, H., Franciszkiewicz, K., Damotte, D., Dieu-Nosjean, M.-C., Validire, P., Trautmann, A., Mami-Chouaib, F., & Donnadieu, E. (2012) · Journal of Clinical Investigation · doi:10.1172/jci45817 · Cited by 1,138
Lin, K. Y., Guarnieri, F., Staveley-O’Carroll, K. F., Levitsky, H. I., August, J. T., Pardoll, D. M., & Wu, T. ‐. (1996) · PubMed · Cited by 1,003
The role of TNF superfamily members in T-cell function and diseases
Croft, M. (2009) · Nature Reviews Immunology · doi:10.1038/nri2526 · Cited by 920
Gros, A., Parkhurst, M. R., Tran, E., Pasetto, A., Robbins, P. F., Ilyas, S., Prickett, T. D., Gartner, J. J., Crystal, J. S., Roberts, I. M., et al. (2016) · Nature Medicine · doi:10.1038/nm.4051 · Cited by 829
Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells
Williams, M. A., Tyznik, A. J., & Bevan, M. J. (2006) · Nature · doi:10.1038/nature04790 · Cited by 797
Helping the CD8+ T-cell response
Bevan, M. J. (2004) · Nature Reviews Immunology · doi:10.1038/nri1413 · Cited by 797
Pipkin, M. E., Sacks, J. A., Cruz-Guilloty, F., Lichtenheld, M. G., Bevan, M. J., & Rao, A. (2010) · Immunity · doi:10.1016/j.immuni.2009.11.012 · Cited by 795
Schietinger, A., Philip, M., Krisnawan, V. E., Chiu, E. Y., Delrow, J. J., Basom, R. S., Lauer, P., Brockstedt, D. G., Knoblaugh, S. E., Hämmerling, G. J., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.07.011 · Cited by 720
Signals required for programming effector and memory development by CD8+ T cells
Mescher, M. F., Curtsinger, J. M., Agarwal, P., Casey, K. A., Gerner, M., Hammerbeck, C. D., Popescu, F., & Xiao, Z. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00382.x · Cited by 601
CD8+ T lymphocyte mobilization to virus-infected tissue requires CD4+ T-cell help
Nakanishi, Y., Lu, B., Gerard, C., & Iwasaki, A. (2009) · Nature · doi:10.1038/nature08511 · Cited by 548
Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4
Hatse, S., Princen, K., Bridger, G., De Clercq, E., & Schols, D. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03143-5 · Cited by 448
Groom, J. R., Richmond, J., Murooka, T. T., Sorensen, E. W., Sung, J. H., Bankert, K., von Andrian, U. H., Moon, J. J., Mempel, T. R., & Luster, A. D. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.016 · Cited by 433
COOPERATION BETWEEN CD4+AND CD8+T CELLS: When, Where, and How
Castellino, F., & Germain, R. N. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115825 · Cited by 376
Wnt Signaling Induces Matrix Metalloproteinase Expression and Regulates T Cell Transmigration
Wu, B., Crampton, S. P., & Hughes, C. C. W. (2007) · Immunity · doi:10.1016/j.immuni.2006.12.007 · Cited by 369
Robust Anti-Viral Immunity Requires Multiple Distinct T Cell-Dendritic Cell Interactions
Eickhoff, S., Brewitz, A., Gerner, M. Y., Klauschen, F., Komander, K., Hemmi, H., Garbi, N., Kaisho, T., Germain, R. N., & Kastenmüller, W. (2015) · Cell · doi:10.1016/j.cell.2015.08.004 · Cited by 337
Nishimura, M., Umehara, H., Nakayama, T., Yoneda, O., Hieshima, K., Kakizaki, M., Dohmae, N., Yoshie, O., & Imai, T. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.6173 · Cited by 326
Nolte, M. A., Van Olffen, R. W., Van Gisbergen, K. P. J. M., & Van Lier, R. A. W. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00774.x · Cited by 305
Weng, N.-P., Araki, Y., & Subedi, K. (2012) · Nature Reviews Immunology · doi:10.1038/nri3173 · Cited by 290
Hor, J. L., Whitney, P. G., Zaid, A., Brooks, A. G., Heath, W. R., & Mueller, S. N. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.020 · Cited by 285
Plasticity in programming of effector and memory CD8+ T‐cell formation
Arens, R., & Schoenberger, S. P. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2010.00899.x · Cited by 207
Naive, Effector and Memory CD8 T-cell Trafficking: Parallels and Distinctions
Nolz, J. C., Starbeck-Miller, G. R., & Harty, J. T. (2011) · Immunotherapy · doi:10.2217/imt.11.100 · Cited by 162
Mitchell, D. M., Ravkov, E. V., & Williams, M. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904089 · Cited by 142
Essential Role for IL-2 in the Regulation of Antiviral Extralymphoid CD8 T Cell Responses
D’Souza, W. N., Schluns, K. S., Masopust, D., & Lefrançois, L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5566 · Cited by 131
CD27 Agonism Plus PD-1 Blockade Recapitulates CD4+ T-cell Help in Therapeutic Anticancer Vaccination
Ahrends, T., Bąbała, N., Xiao, Y., Yagita∥, H., van Eenennaam, H., & Borst, J. G. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3130 · Cited by 131
Self-citationThe CD4+ T-cell help signal is transmitted from APC to CD8+ T-cells via CD27–CD70 interactions
Feau, S., Garcia, Z., Arens, R., Yagita∥, H., Borst, J. G., & Schoenberger, S. P. (2012) · Nature Communications · doi:10.1038/ncomms1948 · Cited by 124
Self-citationCD27-CD70 interactions sensitise naive CD4+ T cells for IL-12-induced Th1 cell development
van Oosterwijk, M. F., Juwana, H., Arens, R., Tesselaar, K., van Oers, M. H. J., Eldering, E., & van Lier, R. A. W. (2007) · International Immunology · doi:10.1093/intimm/dxm033 · Cited by 120
Coquet, J. M., Middendorp, S., Horst, G., Kind, J., Veraar, E. A. M., Xiao, Y., Jacobs, H., & Borst, J. G. (2012) · Immunity · doi:10.1016/j.immuni.2012.09.009 · Cited by 119
Self-citationSiddiqui, I., Erreni, M., van Brakel, M., Debets, R., & Allavena, P. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0125-1 · Cited by 119
Characterization of murine CD70 by molecular cloning and mAb
Oshima, H. (1998) · International Immunology · doi:10.1093/intimm/10.4.517 · Cited by 106
Peperzak, V., Veraar, E. A. M., Keller, A. M., Xiao, Y., & Borst, J. G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000159 · Cited by 93
Self-citationOwen, J. L., Iragavarapu‐Charyulu, V., Gunja‐Smith, Z., Herbert, L. M., Grosso, J. F., & Lopez, D. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4340 · Cited by 89
T Cell Help Amplifies Innate Signals in CD8+ DCs for Optimal CD8+ T Cell Priming
Greyer, M., Whitney, P. G., Stock, A. T., Davey, G. M., Tebartz, C., Bachem, A., Mintern, J. D., Strugnell, R. A., Turner, S. J., Gebhardt, T., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2015.12.058 · Cited by 80
Karlström, S., Nordvall, G., Sohn, D., Hettman, A., Turek, D., Åhlin, K., Kers, A., Claesson, M., Slivo, C., Lo-Alfredsson, Y., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3012273 · Cited by 78
Dunussi‐Joannopoulos, K., Zuberek, K., Runyon, K., Hawley, R. G., Wong, A., Erickson, J., Herrmann, S., & Leonard, J. P. (2002) · Blood · doi:10.1182/blood.v100.5.1551.h81702001551_1551_1558 · Cited by 69
Sakanishi, T., & Yagita∥, H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.092 · Cited by 44
Cited by
Blank, C. U., Haining, W. N., Held, W., Hogan, P. G., Kallies, A., Lugli, E., Lynn, R. C., Philip, M., Rao, A., Restifo, N. P., et al. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0221-9 · Cited by 1,603
CD4+ T cell help in cancer immunology and immunotherapy
Borst, J., Ahrends, T., Bąbała, N., Melief, C. J. M., & Kastenmüller, W. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0044-0 · Cited by 1,585
Self-citationSaxena, M., van der Burg, S. H., Melief, C. J. M., & Bhardwaj, N. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00346-0 · Cited by 1,581
Li, H., van der Leun, A. M., Yofe, I., Lubling, Y., Gelbard-Solodkin, D., van Akkooi, A. C. J., van den Braber, M., Rozeman, E. A., Haanen, J. B. A. G., Blank, C. U., et al. (2019) · Cell · doi:10.1016/j.cell.2018.11.043 · Cited by 1,101
Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
Blass, E., & Ott, P. A. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00460-2 · Cited by 1,042
Metadata
- Authors
- Ahrends, T., Spanjaard, A., Pilzecker, B., Bąbała, N., Bovens, A., Xiao, Y., Jacobs, H., & Borst, J.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 47
- Issue
- 5
- Pages
- 848-861.e5
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2767624281
- Cited by
- 413
- References
- 40
- FWCI
- 12.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.